Abstract: Optic neuropathy is a frequent cause of vision loss encountered by ophthalmologist. The diagnosis is made on clinical grounds. The history often points to the possible etiology of the optic neuropathy. A rapid onset is typical of demyelinating, infl ammatory, ischemic and traumatic causes. A gradual course points to compressive, toxic/nutritional and hereditary causes. The classic clinical signs of optic neuropathy are visual fi eld defect, dyschromatopsia, and abnormal papillary response. There are ancillary investigations that can support the diagnosis of optic neuropathy. Visual fi eld testing by either manual kinetic or automated static perimetry is critical in the diagnosis. Neuro-imaging of the brain and orbit is essential in many optic neuropathies including demyelinating and compressive. Newer technologies in the evaluation of optic neuropathies include multifocal visual evoked potentials and optic coherence tomography.
Diagnosis History
The mode of onset of visual loss is an important clue to the etiology of the optic neuropathy. Rapid onset is characteristic of optic neuritis, ischemic optic neuropathy, infl ammatory (non-demyelinating) and traumatic optic neuropathy. A gradual onset over months is typical of compressive toxic/nutritional optic neuropathy. A more protracted history over years is seen in compressive and hereditary optic neuropathies. The ophthalmologist should make an effort in eliciting history of associated symptoms that can help refi ne the differential diagnosis. In a young patient, history of eye pain associated with eye movement, prior history of neurological symptoms such as paresthesia, limb weakness, and ataxia is suggestive of demyelinating optic neuritis. These neurological complaints may have been misdiagnosed or dismissed by other physicians. For example, chronic arm paresthesia is usually initially misdiagnosed as "carpal tunnel syndrome". Diminution of vision following a rise in body temperature such as following exercise or a hot shower is known as Uhthoff's phenomenon. Although this symptom is usually associated with demyelinating optic neuropathy, it has been reported in a variety of other optic neuropathies including Leber's hereditary optic neuropathy, and optic neuropathy in sarcoidosis (Riordan-Eva et al 1995; Haupert and Newman 1997) .
In an elderly with signs of optic neuropathy, the presence of preceding transient visual loss, diplopia, temporal pain, jaw claudications, fatigue, weight loss and myalgias is strongly suggestive of arteritic ischemic optic neuropathy (AION) due to giant cell arteritis (GCA). In children, history of recent fl u-like illness or vaccination days or weeks before vision loss points to a para-infectious or post-vaccinial optic neuritis, respectively.
Symptoms such as diplopia and facial pain are suggestive of multiple cranial neuropathies seen in infl ammatory or neoplastic lesions of the posterior orbit or Behbehani parasellar region. Transient visual obscurations (periods of vision blackouts lasting seconds caused by change in body position), transient diplopia and headache should raise the suspicion of increased intra-cranial pressure.
The use of any medications should be carefully noted since some are either directly or indirectly toxic to the optic nerve. These include drugs as ethambutol, amiodarone, alcohol, and immunosuppressive medications such as methotrexate and cyclosporine.
History of diabetes, hypertension and hypercholesterolemia is common in patients with non-arteritic ischemic optic neuropathy (NAION) . Patients who are being treated for or have history of malignancy may have infi ltrative or para-neoplastic optic neuropathy.
Inquiry into the patient's general health, eating and social habits (drinking, smoking) is important in suspected toxic/nutritional optic neuropathy. A detailed family history is important in diagnosing hereditary autosomal and mitochondrial optic neuropathies.
Neuro-ophthalmic examination
Acute or chronic vision loss can be caused by any diseases of the anterior visual pathway including the retinal diseases. In many cases, the signs of retinopathy are subtle and it is diffi cult to determine if the cause of vision loss is a retinopathy or optic neuropathy. Therefore, it is important to establish the classic signs of optic neuropathy; visual fi eld defect, decreased color vision, and the presence of relative afferent papillary defect (RAPD).
Visual acuity can be normal or impaired depending on whether the central visual fi eld is affected. In many cases, visual acuity is normal, yet the patient as a large visual fi eld defect that spares the central fi eld. In the optic neuritis treatment trial, 11% of patients had a visual acuity of 20/20 or better (Beck et al 2003) . Color vision can be assessed by using the Ishihara color plates or the American Optical HardyRitter-Rand (AOHRR) pseudoisochromatic color plates. Most patients with acquired optic neuropathy will have dyschromatopsia. However, some patients, especially those with ischemic optic neuropathies may have normal color vision at least in their intact visual fi eld areas. When assessing color vision, it is important to not only assess the number of plates recognized by each eye, but also the speed with which they are recognized and the patients' subjective comparison between each eye. Dyschromatopsia can also occur in macular disease but in this case the visual acuity tends to be profoundly affected. A mild to moderate visual acuity loss in association with dyschromatopsia is a sensitive indicator of optic neuropathy.
A RAPD can be detected by performing the swinging light-pupil test. In the presence of bilateral symmetric optic neuropathy, a RAPD may be absent and the briskness of pupillary constriction to light will refl ect the degree of optic nerve dysfunction. When checking for RAPD, it is important to use a very bright light in a dark room to assess the full amplitude of pupillary response. A RAPD can be estimated subjectively by asking the patient about the difference in brightness of light presented in front of each eye.
Patients with optic neuropathy often have red color desaturation and a red-capped bottle can be presented to each eye and the patient can be asked about the difference in brightness of the red color. A positive response would be that the red color looks "faded", "pink" or "washed out".
Fundus examination may show normal, swollen, pale or anamolous optic disc. The optic disc is usually swollen in NAION and infl ammatory (non-demyelinating) optic neuritis. In demyelinating optic neuritis, however, the optic disc is normal in 65% of cases (retrobulbar neuritis). If disc swelling is present in demyelinating optic neuritis, it is usually mild and diffuse in nature. Severe disc swelling with the presence of hemorrhages and exudates is very atypical of demyelinating optic neuritis and should point to an alternative etiology such as NAION, infl ammatory, or infi ltrative optic neuropathy. In NAION, disc swelling can be sectoral or diffuse and typically associated with peripaillary hemorrhages. A small cup-to-disc ratio (also called disc at risk or congenitally anamolous) is seen in the other eye. Diffuse pallid or "chalky white" swelling with cotton wool spots is usually seen in AION due to GCA. Temporal pallor is seen in conditions that selectively affect the papillo-macular bundle such as toxic/nutritional and hereditary optic neuropathies.
The ophthalmologist should always look for evidence of uveitis such as cells in the anterior vitreous or signs of posterior uveitis such as retinal vasculitis, retinitis, and choroiditis. This would indicate that the disc swelling is secondary to a uveitic process.
A pale optic disc indicates long-standing optic neuropathy such as compressive, hereditary, toxic/nutritional optic neuropathies. This can also occur as a sequel of an acute infl ammatory or ischemic optic neuropathy. Sectoral pallor with retinal arteriole attenuation should point to a previous NAION. When optic atrophy is present, it is possible to detect slit-like or wedge-shaped defects in the peripapillary nerve fi ber layer. The red-free ophthalmoscope is most useful to detect these subtle changes.
Diffuse cupping with pallor occurs in the end stage following AION (Danesh-Meyer et al 2001) . Occasionally, optic disc cupping is seen and the disc appearance may resemble glaucomatous disc cupping. Pallor of the neuro-retinal rim is a specifi c but insensitive sign of non-glaucomatous cupping. Cupping of the optic nerve head has been described in congenital optic disc anamolies, compressive optic neuropathy from large intra-cranial aneurysms or masses, hereditary optic neuropathy (dominant optic atrophy, Leber's mitochondrial optic neuropathy), radiation optic neuropathy and methanol poisoning (Trobe et al 1980a (Trobe et al , 1980b BianchiMarzoli et al 1995) The ophthalmologist should carefully consider these underlying causes before resorting to the diagnosis of "low tension glaucoma".
An anamolous optic nerve indicates a congenital anamoly such as optic nerve hypopolasia, optic nerve coloboma, morning-glory disc anamoly and optic nerve drusen. These entities will not be discussed further and the discussion will be limited to acquired optic neuropathies.
Investigations

Visual fi eld testing
Visual fi led testing is an integral component of the neuroophthalmic examination and is critical in the diagnosis of optic neuropathy. Both manual kinetic or automated static perimetry can be used. The visual fi eld defects in optic neuropathies can take several patterns including central, diffuse, arcuate, and altitudinal defect. The pattern of visual fi led defect is not specifi c of any etiology and almost any type of fi eld defect can occur with any optic neuropathy. However, altitudinal defects are more common in ischemic optic neuropathies and central, or cecocentral defects frequently accompany toxic/nutritional and hereditary optic neuropathies. A cental scotoma affects central fi xation and is due to a lesion in the fovea or papillomacular bundle. A cecocentral sctoma extends from fi xation towards the blindspot and is due to invelvement of the papillomacular bundle arising from the fovea towards the optic disc. A hemianopic defect respecting the vertical midline indicates a lesion at or posterior the chiasm. A junctional scotoma, defi ned as ipsilateral central fi eld defect and contralateral superotemporal fi eld defect indicates a compressive lesion at the junction of the optic nerve and the chiasm.
Contrast sensitivity
Contrast sensitivity is usually reduced in patients with optic neuropathy. Testing charts such as the perri-robson charts can be useful in patients with normal snellen visual acuity. The sensitivity and specifi city of this tool, however, is yet to be determined.
Electrophysiological tests
Visual evoked potential (VEP) can be abnormal in any optic neuropathy but it is no substitute to a careful clinical examination. VEPs measure the cortical activity in response to fl ash or pattern stimulus. They are abnormal in the presence of any lesion along the anterior visual pathway. Although VEP is not necessary in the diagnosis of optic neuropathy, it can be useful in patients with early or sub-clinical optic neuropathy who may have normal pupillary responses and no discernible optic disc changes on clinical examination. VEPs are used commonly in patients with demyelinating disease to detect occult optic nerve dysfunction and to identify a second site of involvement as part of the neurological assessment. Pettern ERG (PERG) can be abnormal in dysfunction of the macula or retinal ganglion cells, which do not contribute signifi cantly to the full fi eld ERG. Therefore, PERG can be useful in a patient with abnormal VEP to identify a macular lesion. A more recent technology, multifocal VEP, has been shown to be of useful values in detecting optic neuritis patients at high-risk patients to develop clinically defi nite multiple sclerosis (Fraser et al 2006) . Panfi eld eletroretinography can be useful to rule out diffuse retinal diseases such as retinitis pigmentosa and multifocal electroretinography can be useful to distinguish macular disease from optic neuropathy.
Optical coherence tomography (OCT)
OCT is a new technology that uses low coherence light to penetrate tissue and a camera to analyze the refl ected image. By performing circular scans around the optic nerve head, the peripapillary nerve fi ber layer can be analyzed. This has been useful in the follow up of patients with optic neuritis, traumatic optic neuropathy, and Leber's hereditary optic neuropathy (Medeiros et al 2003; Barboni et al 2005; Lim et al 2005; Costello et al 2006; Pro et al 2006; Trip et al 2006) . OCT can also be used to document peripaillary nerve fi ber layer thickening in subtle NAION cases and to follow up resolution of disc edema (Savini et al 2006) .
Specifi c diagnosis Acute demyelinating optic neuritis
Because optic neuritis can be the initial manifestation of multiple sclerosis (MS), its recognition is of important prognostic value. Optic neuritis is more common in females with a peak age of onset between 30-40 years (Beck et al 2003) . Magnetic resonance imaging (MRI) of the brain is needed to detect the presence of white matter lesions. The risk of developing clinically defi nite multiple sclerosis over 10 years is 56% if one or more baseline lesion 3 mm diameter Behbehani is found, whereas the risk in normal MRI is 22% (Figure 1 ). The risk is low (5%) in males with severe disc edema with peripaillary hemorrhages and normal MRI (Beck et al 2003) . Initiating treatment with beta-1a interferon should be strongly considered in high-risk patients since this has been found to decrease the risk of conversion to clinically defi nite multiple sclerosis by 50% (Beck et al 2002) .
Optic neuritis improves in 90% of cases over several weeks to near normal visual acuity (Beck 1995) . The use of intravenous steroids was found to hasten the visual recovery but not the fi nal visual outcome (Beck 1995) . However, the early use of steroids may be warranted to minimize axonal loss of the optic nerve, which has been found to occur early in the disease (Arnold 2005; Trip et al 2005; Costello et al 2006) . Lack of improvement after about 4-6 weeks with or without steroids is atypical of optic neuritis and should prompt searching for an alternative causes such as infl ammatory (sarcoid, vasculitis), infi ltrative and compressive. In such cases, the recommended additional investigations include spinal tap, complete blood count, antinuclear antibodies (ANA), chest radiographs, angiotensin converting enzyme levels (ACE), and anti-neutrophil cytoplasmic antibodies (ANCA) (Lee et al 2000) .
Optic neuritis in children is classically thought to differ from adult optic neuritis by frequent bilateral involvement and disc swelling, and more severe initial vision Figure 2 ). Other neurological manifestations may occur if there is concurrent acute disseminated encephalomyelitis (Bangsgaard et al 2006) . MRI of the brain and orbit is recommended to rule out demyelination, and meningeal enhancement seen in infectious or non-infectious meningitis. Contrary to the common notion that childhood optic neuritis is less likely to be associated with multiple sclerosis (Lucchinetti et al 1997) , a recent report found an association with MS in 36% of patients with optic neuritis, especially with bilateral involvement (Wilejto et al 2006) .
Neuromyelitis optica (Devic's disease)
When optic neuritis is preceded or followed by transverse or ascending myelopathy often causing paraplegia, the condition is referred to as neuromyelitis optica (NMO). This condition is more common in young patients with a predilection for Asians and Africans (Cabre et al 2001; Nakashima et al 2006) . The visual loss is often severe, bilateral and may precede or follow the myelopathy. The interval between myelopathy and optic neuritis can be months to years. MRI of the spine will show demyelination extending over 3 or more vertebral segments. There is a debate about whether NMO is simply a sub-type of MS (Rubiera et al 2006) . Although, lesions outside the optic nerve and spinal cord were considered incompatible with NMO, the criteria of diagnosis have been revised recently to allow for the presence of MRI brain lesion "not compatible with MS" (Pittock et al 2006; Wingerchuk et al 2006) . A serum marker, NMO Ig-G, has been found useful to distinguish NMO from other related disorders such as MS (Lennon et al 2004) .
Non-arteritic ischemic optic neuropathy (NAION)
NAION can occasionally be confused with acute demyelinating optic neuritis. There are some features that may help distinguishing the two conditions. The presence of severe disc edema with hemorrhages is characteristic of NAION and atypical of optic neuritis (Figure 3 ). Patients with NAION are usually over 50 years old and have systemic vascular risk factors such as diabetes, hypertension, and smoking (Tsai et al 1998; McCulley et al 2005) . Nevertheless, NAION can occur in young patients (below 45 years) and patients who lack any vascular risk factors. In young patients, it has been associated with hypercholesterolemia and hyperhomocysteinemia (Pianka et al 2000; Deramo et al 2003) . Visual acuity can be normal or severely affected. The visual fi eld defect is usually inferonasal arcuate or altitudinal. The optic nerve head in the other eye is often has small cup-to-disc ratio (0.1 or less) (Burde 1993; Feldon 1999 ). This optic nerve head confi guration seems to play a more important role than the systemic risk factors (Tsai et al 1998) . Recent reports have linked NAION to the sleep apnea syndrome (Mojon et al 2002; Palombi et al 2006) , but it is unknown whether treatment of sleep apnea can prevent NAION (Behbehani, Mathews et al 2005) . Visual acuity usually remains static or improves slightly in the vast majority of patients with NAION (Arnold and Hepler 1994) . In a small subset of patients, visual acuity may actually worsen over the fi rst few weeks (progressive NAION) (Sergott et al 1989; Spoor et al 1993; Arnold and Hepler 1994) . This progressive phase may cause a diagnostic diffi culty but it rarely lasts more than 3-4 weeks and is then followed by stabilization of visual function. Bilateral simultaneous involvement is very unusual of NAION and but can occur during a hypotensive episode such as blood loss or over-dosing of anti-hypertensive medications (Hayreh 1999) . Recurrence in the same eye is uncommon with a risk of 5% (Hayreh et al 2001) . The risk 
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of later involvement in the follow eye within 5 years is 15% (Newman et al 2002) .
In posterior ischemic optic neuropathy (PION) there is no disk swelling. PION can occur in severe blood loss, hypotension, hemodialysis, anemia, and after long surgeries, such as spinal surgeries, in which the patient is positioned prone (Buono et al 2003; Murphy 2003; Hayreh 2004) . The visual loss is often bilateral but can be asymmetrical. Pupillary responses to light will be sluggish, which helps distinguish PION from a cortical cause of vision loss.
Arteritic ischemic optic neuropathy (AION)
In patients over 60 year old with features of ischemic optic neuropathy, the ophthalmologist should strongly consider the possibility of giant cell arteritis (GCA). Careful medical history should be obtained, inquiring about temporal pain, jaw claudications, transient visual or diplopia, fever, weight loss, myalgias and fatigue (Hayreh et al 1998b) . Some patients may not have the constitutional symptoms and have only visual symptoms (occult GCA) (Liu et al 1994; Hayreh et al 1998a) . Other clinical features that may help distinguishing patients with AION from NAION include cup-to-disk ratio of greater than 0.2 in the other eye, early massive or bilateral simultaneous visual loss, markedly pallid disk edema often described as "chalky-white" swelling in 68.7% of cases, and choroidal infarcts (Figure 4 ) (Hayreh et al 1998a (Hayreh et al , 1998b . Rarely, the optic disc can look normal (PION) (Sadda et al 2001) . End-stage optic disc appearance of patients with AION is characterized by marked cupping with pallor and should not be confused The superfi cial temporal arteries should be palpated and the pulse felt. Patients with GCA have a "cord-like" feel with reduced pulses.
Laboratory evaluation should include complete blood count, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). ESR is elevated in GCA but 2-30% of patients with biopsy-proven GCA will have normal ESR (Brittain et al 1991; Liu, Glaser et al 1994; Hayreh et al 1997; Salvarani and Hunder 2001) . Elevated CRP was found to be more sensitive (97.5%) than ESR (76%-86%) for the detection of GCA. ESR and CRP combined give the best specifi city (97.0%) and sensitivity (99%) for diagnosis (Hayreh et al 1997; Parikh et al 2006) . Thrombocytosis is another useful feature that can complement ESR and CRP (Lincoff et al 2000; Costello et al 2004) .
Steroid treatment should be instituted in patients who are considered at high risk to have GCA based on the clinical and laboratory features. Untreated GCA will cause visual loss in the fellow eye in about a third of cases with the risk highest in the fi rst 4 weeks. Either oral (80-120 mg prednisone) or intravenous (1 gram methyleprdnisolone) for 3-5 days followed by oral steroids can be used. There is no evidence that either route of administration is more effective in preventing possible early visual deterioration (Hayreh and Zimmerman 2003) . There are reports of the successful use of heparin if visual deterioration occurs despite being on steroid treatment (Buono et al 2004) .
Defi nitive diagnosis of AION is established by temporal artery biopsy and histopathological confi rmation. Although the infl ammation can be seen histopathologically in the vessels for weeks despite steroid therapy, temporal artery biopsy should be performed as soon as the patient is started on steroids to avoid equivocal results. Jaw claudications and neck pain are signifi cant indicators of a positive temporal artery biopsy independent of the ESR and CRP (Hayreh et al 1997) The odds ratio for a positive temporal artery biopsy was 9.0 times greater with jaw claudications, 3.3 greater with neck pain, and 3.2 greater with an elevated ESR and CRP (Hayreh et al 1997) . Biopsy can be performed on one side and if it is negative and the index of suspicion of GCA is high, a biopsy is performed the contra-lateral side. Some authors advocate bilateral temporal artery biopsies at the onset because an overall chance of discordance of 4%-5% (Danesh-Meyer et al 2000; Pless et al 2000) .
Infl ammatory (non-demyelinating) optic neuropathy
This category comprises many entities in which the optic nerve is involved by either an ocular or systemic infl ammatory process. Optic disc swelling frequently occurs with posterior uveitis and retinitis. Therefore, when evaluating optic disk swelling, it is useful to look for evidence of anterior or posterior segment infl ammation. Optic neuropathy can also occur in the context orbital infl ammatory disease (orbital pseudotumor). MRI of the orbit will show infl ammation of the optic nerve sheath (optic perineuritis) (Fay et al 1997) .
The optic nerve can be involved in a variety of systemic auto-immune and infectious disorders such as sarcoidosis, systemic lupus erythematosus, Behcet's disease infl ammatory bowel disease, Sjogren's syndrome Wegener's granulomatosis, syphilis, Lyme disease and cat-scratch disease (Jabs et al 1986; Wise and Agudelo 1988; Kansu et al 1989; Belden et al 1993; Han et al 2006) .
Auto-immune optic neuropathy is a recurrent, steroidresponsive optic neuropathy. The anti-nuclear antibody (ANA) and anticardiolipin antibody are frequently positive (Kupersmith et al 1988; Frohman et al 2003) . The diagnosis is made by performing a skin biopsy, which often shows evidence of vasculitis when studied with immunofl orescence.
Chronic relapsing infl ammatory optic neuropathy is another entity characterized by recurrences and steroidresponsiveness. The syndrome can behave as granulomatous optic neuropathy and may require long-term immunosuppressive therapy (Kidd et al 2003) .
Some of the features that should raise the suspicion of an infl ammatory optic neuritis include lack of spontaneous improvement of visual function after 30 days, or exquisite steroid-responsiveness and steroid-dependency. In such cases, a spinal tap and additional laboratory studies directed by the history and neuro-ophthalmic examination are indicated (see discussion under demyelinating optic neuritis).
Infi ltrative optic neuropathies
The optic nerve can be infi ltrated in systemic malignancies such as lymphoma, leukemia, multiple myeloma, and carcinoma (Brown et al 1981; Brazis et al 1990; Behbehani, Vacarezza et al 2005; Shimada et al 2006) . The optic disc can be swollen or normal in appearance ( Figure 5) . MRI of the brain and orbit may show meningeal and optic nerve enhancement. Spinal tap is recommended in cases of suspected CNS malignancy but more than one spinal tap may be needed to detect malignant cells (van Oostenbrugge and Twijnstra 1999) In case of localized optic nerve infi ltration with no evidence of systemic disease, histopathological diagnosis may require direct optic nerve sheath biopsy (Behbehani, Vacarezza et al 2005) .
Compressive optic neuropathy
In compressive optic neuropathy, visual loss is usually gradual and progressive. Common causes include orbital and intracranial meningiomas, pituitary adenomas, intracranial aneurysms, craniopharyngiomas, and gliomas of the anterior visual pathway (Figure 6 ). Vision loss, however, can be fast and dramatic in pituitary apoplexy, or ruptured aneurysm. Visual fi eld testing aids in the localization of the lesion and neuro-imaging with MRI of the brain and orbit is essential.
Compressive optic neuropathy can also occur in thyroid eye disease and can present as asymmetric progressive visual loss. This will require prompt therapy (orbital radiation, orbital decompression, high-dose systemic steroids).
Hereditary optic neuropathy
The hereditary optic neuropathies are a broad category including autosomally inherited diseases (dominant, recessive, X-linked) and diseases caused by inheritance of defective mitochondrial genome. Mitochondrial dysfunction may be a fi nal common pathway among these disorders (Newman 2005; Atkins et al 2006) . Hereditary optic neuropathies can be isolated or associated with other neurological signs and symptoms.
Patients with dominant optic neuropathy (Kjers' type) often present in the fi rst decade of life with bilateral symmetric visual loss. Visual acuity can range from 20/20 to 20/400 (Hoyt 1980; Das et al 2006) . Visual fi eld testing frequently reveals bilateral central or cecocentral scotomas. In some cases, a central hemianopic bitemporal visual fi eld defect is found, which in the absence of positive family history may erroneously lead to a search for a chiasmal lesion (Manchester and Calhoun 1958) . Patients will have color vision defi cit along the tritan (blue-yellow) axis. The optic disc will show temporal pallor and in some cases severe excavation and cupping. There various responsible genetic mutations occur in the OPA1 gene located on the chromosome 3 q region (Votruba 2004) .
Clinical approach to optic neuropathies
Recessive optic neuropathy is rare and tends to present in the fi rst year of life (Francois 1976) . It can be associated with diabetes mellitus, diabetes inspidus, and deafness (Wolfram syndrome) (Ajlouni et al 2002) . An X-linked optic atrophy has also been described and the genetic mutation has been localized to Xp11.4-Xp11.2 (OPA2) (Katz et al 2006) . Optic neuropathy can also occur in neurological conditions such as spinocerebellar degeneration, Friedriech's ataxia, and olivo-ponto-cerebellar atrophy.
Leber's hereditary mitochondrial optic neuropathy (LHON) classically presents with acute unilateral, painless, visual loss. However, some cases may stay asymptomatic or have a chronic course (Kerrison 2005) . Sequential bilateral involvement may occur weeks or months later. Visual fi led defects tend to be central or cecocentral as the papillo-macular bundle is fi rst and most severely affected (Barboni et al 2005) . Fundoscopy may show disk swelling, thickening of the peripapillary retinal nerve fi ber layer and peripapillary retinal telangectatic vessels which do not leak on fl ourescin angiography (Figure7). Occasionally, optic nerve pallor can be seen initially. Because of the wide age range (6-80 years old) at which LHON may present, it is frequently misdiagnosed (Ajax and Kardon 1998) . Young patients are often diagnosed as optic neuritis and older patients as ischemic or infi ltrative optic neuropathy. MRI may show optic nerve enhancement and white matter lesions, which may add to the diagnostic diffi culties (Paulus et al 1993; Vaphiades and Newman 1999) . Therefore, a high index of suspicion is essential. Some patients may spontaneously improve to normal or near normal visual acuity (Nakamura and Yamamoto 2000) .
LHON has 4 primary mitochondrial genome mutations; G11778A, G3460A and T14484C and T10663C. The disease affects males more than females with a ratio of 2.5:1 for the G11778A and G3460A mutation and 6:1 ratio for the T14484C mutation (Riordan-Eva et al 1995) . The frequencies of mutation may vary across different countries and newer mutations have been described worldwide (Zhadanov et al 2005; Houshmand et al 2006) . Some patients may demonstrate neurological manifestations such as peripheral neuropathy, ataxia, dystonia and cardiac conduction defects (Bower et al 1992; Murakami et al 1996; Watanabe et al 2006) . These patients fall in the spectrum mitochondrial encephalomyelopathies and their clinical manifestations may vary considerably (Gropman et al 2004; Blakely et al 2005) .
Toxic-nutritional optic neuropathies
Optic nerve dysfunction can be caused by various drugs, toxins and nutritional defi ciencies. The most common offenders are ethambutol, amiodarone, methanol, ethanol and tobacco (DeVita et al 1987; Purvin et al 2006) . Similar to hereditary optic neuropathies, toxic-nutritional optic neuropathies are also characterized by selective maculo-papillar bundle involvement, leading to central or cecocentral scotomas. Ethambutol causes optic neuropathy in 1% of patients using the anti-tuberculous medication. Although the dosage of 25 mg/kg/day for 2 months followed by 15 mg/kg/day maintenance doses is considered safe, toxicity has been reported at below this dosage (Tsai and Lee 1997) . Patients with low zinc levels were found to be more vulnerable to develop optic neuropathy (De Palma et al 1989) . The visual symptoms usually start 2-8 months after the drug is started. Pupillary abnormalities can be subtle, and visual evoked potential may be needed to confi rm the diagnosis. The diagnosis is often made late when optic nerve pallor has already set in and vision is severely affected. The drug should be stopped as soon as the diagnosis is made, although in advanced cases vision continues to deteriorate even following drug cessation.
The anti-arrhythmic drug amiodarone can cause bilateral optic neuropathy. Because patients using this drug have systemic vascular risk factors, there is still controversy whether patients affected may simply have NAION. Some of the clinical features that may help distinguish this entity from NAION are the bilateral simultaneous onset, the insidious nature of vision loss, and the protracted disc edema which can last for months (Murphy and Murphy 2005; Purvin et al 2006) . The disc edema in NAION usually resolves within 6-8 weeks.
Other medications which can cause toxic optic neuropathy include methotrexate, cyclosporine, vincristine, cisplatin and chloramphenicol (Godel et al 1980; Walter et Tobacco-alcohol amblyopia is a term used for a condition that may be due both the toxic effect of the tobacco and a nutritional defi ciency state. Because many patients who abuse alcohol and tobacco do not get optic neuropathy, the mechanism is unlikely to be a direct insult to the optic nerve. A more plausible mechanism is that genetic and nutritional defi ciency factors increase the susceptibility for optic neuropathy for the effects of certain toxins. Defi ciency of thiamine (B 1 ), ribofl avin (B 2 ), folate, B 12 and B 6 have all been associated with optic neuropathy (Rizzo and Lessell 1993; Golnik and Schaible 1994; Sadun et al 1994; Hsu et al 2002) . Patients who follow high protein, ketogenic and low carbohydrate diet are at risk for developing thiamin defi ciency. Similarly, patients who have undergone gastrointestinal surgery may develop optic neuropathy due interference with the absorption of vitamin B 12 . Clinical approach to optic neuropathies
Radiation optic neuropathy (RON)
Patients with RON can present with vision loss, months or years following history of radiation exposure to the brain or orbit. The risk increases in patients who had also received chemotherapy (Kline et al 1985) . The mechanism of RON is ischemia caused by endothelial cell injury from radiation. The optic disc is usually normal but can be swollen. MRI of the orbit may show optic nerve enhancement with gadolinium (Guy et al 1990; Lessell 2004) . Patients may also have radiation retinopathy with retinal hemorrhages, cotton wool spots, exudates and macular edema. Because many of those patients were treated for brain or orbital tumors, recurrent tumor is initially the main consideration when patients become symptomatic. There is no treatment of proven effi cacy for RON. Hyperbaric oxygen, steroids, antiplatelet drugs, and anticoagulants have all been used with limited success (Barbosa et al 1999; Danesh-Meyer et al 2004; Boschetti et al 2006) . The visual prognosis is poor with 45% of eyes ending with no light perception visual acuity (Lessell 2004) .
Traumatic optic neuropathy
Traumatic optic neuropathy presents with typical signs and symptoms. Patients usually had suffered craniofacial trauma but occasionally mild orbital or eye injury (Hou and Murphy 2004; Nishi et al 2006) . A RAPD is the main clue to the diagnosis. CT scan of the orbit is recommended to detect any bony fractures, fractures of the optic canal, and acute orbital hemorrhages. High-dose steroid therapy was adopted as a treatment because of their benefi cial effect in studies on spinal cord injuries. Subsequently, however, it was shown that high-dose steroids may be harmful to the optic nerve if started 8 hours after the injury (Steinsapir 2006) . In a non-randomized trial, no clear benefi t was found with either steroids or surgical decompression of the optic canal (Levin et al 1999) . There are anecdotal reports of benefi cial outcome of surgery in cases of optic canal fracture and optic nerve sheath hematoma (Jiang et al 2001; Wohlrab et al 2002; Rajiniganth et al 2003) .
Paraneoplastic optic neuropathy
Optic neuropathy can occur as a remote effect of both small cell and non-small cell lung carcinoma of the lung (Asproudis et al 2005; Sheorajpanday et al 2006) . Some patients may have a concurrent paraneoplastic cerebellar syndrome of dysarthria and ataxia (Luiz et al 1998; Thambisetty et al 2001) . Patients often have bilateral disc swelling and progressive visual loss before the diagnosis of the systemic malignancy is made. The collapsing response-mediating protein (CRMP-5) has been found recently to be a useful marker in the diagnosis of this condition in patients with lung carcinoma (Yu et al 2001; Calvert 2006) .
Conclusion
Optic neuropathy can be caused by demyelination, infl ammation, ischemia, infi ltration, compression, and hereditary and toxic/nutritional causes. Careful clinical evaluation is essential to rule in the diagnosis of optic neuropathy. Recognition of same entities can not only alter the visual prognosis but also the neurological prognosis. Some additional tests particularly visual fi eld testing and neuro-imaging are very useful in the clinical evaluation. The ophthalmologist should be familiar with the various entities that can cause optic neuropathy. With careful clinical evaluation and appropriate investigations, a specifi c diagnosis can be made in most cases.
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